1. Academic Validation
  2. Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors

Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors

  • Nat Commun. 2024 Dec 30;15(1):10801. doi: 10.1038/s41467-024-55083-3.
Sara Orehek 1 2 Taja Železnik Ramuta 1 Duško Lainšček 1 3 4 Špela Malenšek 1 2 Martin Šala 5 Mojca Benčina 1 4 6 Roman Jerala 1 3 4 Iva Hafner-Bratkovič 7 8 9
Affiliations

Affiliations

  • 1 Department of Synthetic Biology and Immunology, National Institute of Chemistry, Ljubljana, Slovenia.
  • 2 Interdisciplinary Doctoral Study of Biomedicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • 3 EN-FIST Centre of Excellence, Ljubljana, Slovenia.
  • 4 Centre for the Technologies of Gene and Cell Therapy, National Institute of Chemistry, Ljubljana, Slovenia.
  • 5 Department of Analytical Chemistry, National Institute of Chemistry, Ljubljana, Slovenia.
  • 6 Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.
  • 7 Department of Synthetic Biology and Immunology, National Institute of Chemistry, Ljubljana, Slovenia. iva.hafner@ki.si.
  • 8 EN-FIST Centre of Excellence, Ljubljana, Slovenia. iva.hafner@ki.si.
  • 9 Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. iva.hafner@ki.si.
Abstract

Inflammasomes are defense complexes that utilize cytokines and immunogenic cell death (ICD) to stimulate the immune system against pathogens. Inspired by their dual action, we present cytokine-armed Pyroptosis as a strategy for boosting immune response against diverse types of tumors. To induce Pyroptosis, we utilize designed tightly regulated gasdermin D variants comprising different pore-forming capabilities and diverse modes of activation, representing a toolbox of ICD inducers. We demonstrate that the electrogenic transfer of ICD effector-encoding plasmids into mouse melanoma tumors when combined with intratumoral expression of cytokines IL-1β, IL-12, or IL-18, enhanced anti-tumor immune responses. Careful selection of immunostimulatory molecules is, however, imperative as a combination of IL-1β and IL-18 antagonized the protective effect of Pyroptosis by IFNγ-mediated upregulation of several immunosuppressive pathways. Additionally, we show that the intratumoral introduction of armed Pyroptosis provides protection against distant tumors and proves effective across various tumor types without inducing systemic inflammation. Deconstructed inflammasomes thus serve as a powerful, tunable, and tumor-agnostic strategy to enhance antitumor response, even against the most resilient types of tumors.

Figures
Products